Cargando…

Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation

Aim: SARS-CoV-2, an emerging betacoronavirus, is the causative agent of COVID-19. Currently, there are few specific and selective antiviral drugs for the treatment and vaccines to prevent contagion. However, their long-term effects can be revealed after several years, and new drugs for COVID-19 shou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cava, Claudia, Bertoli, Gloria, Castiglioni, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293696/ https://www.ncbi.nlm.nih.gov/pubmed/34306168 http://dx.doi.org/10.2217/fvl-2020-0392

Ejemplares similares

In Silico Discovery of Candidate Drugs against Covid-19
por: Cava, Claudia, et al.
Publicado: (2020)

A protein interaction map identifies existing drugs targeting SARS-CoV-2
por: Cava, Claudia, et al.
Publicado: (2020)

In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
por: Cava, Claudia, et al.
Publicado: (2018)

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
por: Cava, Claudia, et al.
Publicado: (2015)

Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project
por: D’Antona, Salvatore, et al.
Publicado: (2021)

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues
por: Cava, Claudia, et al.
Publicado: (2019)

Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy
por: Cava, Claudia, et al.
Publicado: (2018)

Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer
por: Colaprico, Antonio, et al.
Publicado: (2015)

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of New Drugs against Human Topoisomerase I Receptor
por: Madeddu, Francesco, et al.
Publicado: (2022)

Molecular Dockings and Molecular Dynamics Simulations Reveal the Potency of Different Inhibitors against Xanthine Oxidase
por: Pan, Yue, et al.
Publicado: (2021)

Phytochemicals as potential inhibitors for COVID-19 revealed by molecular docking, molecular dynamic simulation and DFT studies
por: Puthanveedu, Vinduja, et al.
Publicado: (2022)

In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis
por: Gallivanone, Francesca, et al.
Publicado: (2019)

Molecular Dynamic Simulations and Molecular Docking as a Potential Way for Designed New Inhibitor Drug without Resistance
por: Aghajani, Jafar, et al.
Publicado: (2022)

Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
por: Santo, Giulia Dal, et al.
Publicado: (2022)

Molecular Docking and Dynamics Simulation Revealed Ivermectin as Potential Drug against Schistosoma-Associated Bladder Cancer Targeting Protein Signaling: Computational Drug Repositioning Approach
por: Siddiqui, Arif Jamal, et al.
Publicado: (2021)

Screening of Potential Breast Cancer Inhibitors through Molecular Docking and Molecular Dynamics Simulation
por: Pandi, Sangavi, et al.
Publicado: (2022)

Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition
por: Cava, Claudia, et al.
Publicado: (2014)

How interacting pathways are regulated by miRNAs in breast cancer subtypes
por: Cava, Claudia, et al.
Publicado: (2016)

Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
por: Cava, Claudia, et al.
Publicado: (2018)

In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer
por: Cava, Claudia, et al.
Publicado: (2018)

QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against Streptococci
por: Ye, Jiqing, et al.
Publicado: (2022)

Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation to Elucidate the Molecular Targets and Potential Mechanism of Phoenix dactylifera (Ajwa Dates) against Candidiasis
por: Adnan, Mohd, et al.
Publicado: (2023)

Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
por: El-hoshoudy, A.N.
Publicado: (2020)

Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations
por: Lazniewski, Michal, et al.
Publicado: (2022)

Phenolic compounds as promising drug candidates against COVID-19 - an integrated molecular docking and dynamics simulation study
por: Davella, Rakesh, et al.
Publicado: (2022)

Molecular docking and dynamic simulations of benzimidazoles with beta-tubulins
por: Rao, Chennu Maruthi Malya Prasada, et al.
Publicado: (2021)

Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study
por: De Benedittis, Selene, et al.
Publicado: (2021)

Lichen planus drugs re-purposing as potential anti COVID-19 therapeutics through molecular docking and molecular dynamics simulation approach
por: Soni, Unnati, et al.
Publicado: (2022)

Docking Studies and Molecular Dynamic Simulations Reveal Different Features of IDO1 Structure
por: Greco, Francesco Antonio, et al.
Publicado: (2016)

Identification of Breast Cancer Subtype-Specific Biomarkers by Integrating Copy Number Alterations and Gene Expression Profiles
por: Cava, Claudia, et al.
Publicado: (2021)

Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021)

Homology Modeling, Molecular Docking, Molecular Dynamic Simulation, and Drug-Likeness of the Modified Alpha-Mangostin against the β-Tubulin Protein of Acanthamoeba Keratitis
por: Ongtanasup, Tassanee, et al.
Publicado: (2022)

Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations
por: Rashid, Rebwar Saeed M., et al.
Publicado: (2023)

High-Performance Drug Discovery: Computational Screening by Combining Docking and Molecular Dynamics Simulations
por: Okimoto, Noriaki, et al.
Publicado: (2009)

Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2
por: Subhaswaraj, Pattnaik, et al.
Publicado: (2022)

Phloroglucinol as a Potential Candidate against Trypanosoma congolense Infection: Insights from In Vivo, In Vitro, Molecular Docking and Molecular Dynamic Simulation Analyses
por: Abdulrashid, Nasirudeen Idowu, et al.
Publicado: (2022)

An Investigation of the Antiviral Potential of Phytocompounds against Avian Infectious Bronchitis Virus through Template-Based Molecular Docking and Molecular Dynamics Simulation Analysis
por: Gul, Irfan, et al.
Publicado: (2023)

Repurposing Amphotericin B: anti-microbial, molecular docking and molecular dynamics simulation studies suggest inhibition potential of Amphotericin B against MRSA
por: Farid, Neha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_frtgtma7gdht2grncbguej5mbv